Abstract
The authors combine expertise in market development with direct experience in cancer vaccine development to provide a concise analysis of this market including the current trends, and market forecast. This Report provides a comprehensive analysis of therapeutics currently in development, as well as those that have been discontinued. Development strategies are also discussed in detail. Primary market research was utilized to elucidate the opinions of cancer vaccine developers, and responses from these experts are included throughout the Report. | 
View Cart
